Alpha Tau Medical Ltd. is a clinical-stage biotechnology company dedicated to the advancement and eventual commercialization of innovative cancer treatments. Their primary focus is on "Alpha DaRT" (Diffusing Alpha-Emitters Radiation Therapy), a novel approach designed to combat solid tumors. This therapeutic radiation technique is currently undergoing clinical evaluation for various solid malignancies, including skin, oral, pancreatic, and breast cancers, with development efforts primarily concentrated in Israel and the United States.